NCT04465266View on ClinicalTrials.gov

A Phase 1 PK Study of Tolperisone in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

August 21, 2020

Study Completion Date

September 1, 2021

Conditions
Healthy
Interventions
DRUG

Tolperisone

tablets

Trial Locations (1)

78217

Worldwide Clinical Trials Early Phase Services, LLC, San Antonio

Sponsors
All Listed Sponsors
lead

Neurana Pharmaceuticals, Inc.

INDUSTRY